Founded in 1974, New York Blood Center Enterprises’ Lindsley F. Kimball Research Institute (LFKRI) is a leading hematology and transfusion medicine research center. LFKRI studies blood and fights bloodborne/related diseases like AIDS, hepatitis, malaria, and leukemia, enabling healthier lives. Supported by NYBCe and ~$12-16M annual NIH grants, LFKRI's groundbreaking research yields patents/licenses in transfusion medicine, hematology, infectious disease, epidemiology, and cellular therapy.
Images
Welcome to Rye Bio, which offers a unique opportunity for early- to mid-stage life science companies to grow and innovate within a world-renowned research ecosystem. Housed within NYBCe’s Lindsley F. Kimball Research Institute (LFKRI) — a leader in hematology, cellular therapies, and related fields — this flexible incubator space provides companies with state-of-the-art laboratory facilities, specialized equipment, and on-site expertise.
Ribbon-cutting ceremony at New York Blood Center Enterprises life sciences campus in Rye, NY. Home to the labs of the Lindsley F. Kimball Research Institute.
Frequently Asked Questions
When was Lindsley F. Kimball Research Institute of New York Blood Center founded?
Lindsley F. Kimball Research Institute of New York Blood Center was founded in 1964.
What are Lindsley F. Kimball Research Institute of New York Blood Center main services?
basic applied research, hematology, transfusion medicine, Rye Bio, cellular therapies, incubator research space, tate-of-the-art laboratory facilities, scientific research consulting, diagnostic platform, biotechnology, laboratory space rental.
Attention business owner!
Register your business now and enhance your global reach with iGlobal.